Assembly Biosciences, Inc generated $72.3M in revenue in fiscal year 2025. This represents an increase of 153.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $74.8M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Assembly Biosciences, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ASMB Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
ASMB Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Assembly Biosciences, Inc financials
Frequently Asked Questions
What was Assembly Biosciences, Inc's revenue in fiscal year 2025?
Assembly Biosciences, Inc generated $72.3M in revenue in fiscal year 2025.
How fast is Assembly Biosciences, Inc's revenue growing?
Assembly Biosciences, Inc (ASMB) revenue rose by 153.5% year over year, from $28.5M to $72.3M in fiscal year 2025.
What is Assembly Biosciences, Inc's revenue over the last twelve months?
Assembly Biosciences, Inc (ASMB) reported $74.8M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was Assembly Biosciences, Inc's revenue in the most recent quarter?
Assembly Biosciences, Inc (ASMB) reported $13.4M in revenue in Q2 2026. This represents an increase of 38.9% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Assembly Biosciences, Inc (ASMB) reported on that line in every period on record.